Korea FDA OKs Samsung's Clinical Trial Application For Roche's MabThera Biosimilar

SEOUL - Korea FDA approved March 8 Samsung Electronics' investigational new drug application to commence Phase I clinical trials of a biosimilar of Roche's MabThera, marking the first step of the electronics and semiconductor giant's ambition to enter the healthcare sector